Patent Assignment
Reel/Frame 041646/0415
Assignment of Assignor's Interest
Recorded: 2017-03-20
Pages: 3
Assignor
FLANAGAN, SHAWN
Executed: 2011-12-01
Assignee
OREXIGEN THERAPEUTICS, INC.
3344 NORTH TORREY PINES COURT, SUITE 200, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Increasing Drug Bioavailability in Naltrexone Therapy
Application:
13/991,137 →
Publication:
US 2013/0245056
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 20, 2017
From: DUNAYEVICH, EDUARDO
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041648/0415 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Assignment of Assignor's Interest
Oct 24, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 048102/0478 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →